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ABSTRACT Leishmania spp. are protozoan parasites that cause a spectrum of im-
portant diseases in humans. These parasites develop as extracellular promastigotes
in the digestive tract of their insect vectors and as obligate intracellular amastigotes
that infect macrophages and other phagocytic cells in their vertebrate hosts.
Promastigote-to-amastigote differentiation is associated with marked changes in me-
tabolism, including the upregulation of enzymes involved in fatty acid -oxidation,
which may reflect adaptation to the intracellular niche. Here, we have investigated
the function of one of these enzymes, a putative 2,4-dienoyl-coenzyme A (CoA) re-
ductase (DECR), which is specifically required for the -oxidation of polyunsaturated
fatty acids. The Leishmania DECR shows close homology to bacterial DECR proteins,
suggesting that it was acquired by lateral gene transfer. It is present in other
trypanosomatids that have obligate intracellular stages (i.e., Trypanosoma cruzi and
Angomonas) but is absent from dixenous parasites with an exclusively extracellular
lifestyle (i.e., Trypanosoma brucei). A DECR-green fluorescent protein (GFP) fusion
protein was localized to the mitochondrion in both promastigote and amastigote
stages, and the levels of expression increased in the latter stages. A Leishmania ma-
jor Δdecr null mutant was unable to catabolize unsaturated fatty acids and accumu-
lated the intermediate 2,4-decadienoyl-CoA, confirming DECR’s role in -oxidation.
Strikingly, the L. major Δdecr mutant was unable to survive in macrophages and was
avirulent in BALB/c mice. These findings suggest that -oxidation of polyunsaturated
fatty acids is essential for intracellular parasite survival and that the bacterial origin
of key enzymes in this pathway could be exploited in developing new therapies.
IMPORTANCE The Trypanosomatidae are protozoan parasites that infect insects,
plants, and animals and have evolved complex monoxenous (single host) and dix-
enous (two hosts) lifestyles. A number of species of Trypanosomatidae, including
Leishmania spp., have evolved the capacity to survive within intracellular niches in
vertebrate hosts. The adaptations, metabolic and other, that are associated with de-
velopment of intracellular lifestyles remain poorly defined. We show that genomes
of Leishmania and Trypanosomatidae that can survive intracellularly encode a 2,4-
dienoyl-CoA reductase that is involved in catabolism of a subclass of fatty acids. The
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trypanosomatid enzyme shows closest similarity to the corresponding bacterial en-
zymes and is located in the mitochondrion and essential for intracellular growth of
Leishmania. The findings suggest that acquisition of this gene by lateral gene trans-
fer from bacteria by ancestral monoxenous Trypanosomatidae likely contributed to
the development of a dixenous lifestyle of these parasites.
KEYWORDS Kinetoplastida, lateral gene transfer, mitochondrial metabolism,
virulence factors
Leishmania spp. are flagellated protozoan parasites (order Trypanosomatida, phylumKinetoplastida) that cause a spectrum of diseases, ranging from localized cutaneous
ulcers to disseminating, lethal visceral leishmaniases (1). Leishmania spp. have a dix-
enous lifestyle, infecting both insect and vertebrate hosts. Flagellated extracellular
promastigotes reside in the digestive tract of their sandfly vector and are transmitted
into the skin of the mammalian host during a blood meal. After uptake by host
phagocytes, promastigotes differentiate to nonflagellated intracellular amastigotes and
replicate within the phagolysosomal compartment of macrophages, known as the
parasitophorous vacuole (PV) (2).
Although the taxonomy and phylogeny of Trypanosomatidae are still under inves-
tigation (3–5), it is now accepted that all known trypanosomatids are parasitic and
found primarily in insects (6). In contrast to monoxenous trypanosomatids, which
exclusively infect and reside within a single invertebrate host, dixenous Leishmania and
Trypanosoma species alternate between insect and vertebrate hosts and have been
extensively investigated due to their medical relevance. The dixenous and intracellular
lifestyle is likely to have been associated with gene acquisitions and losses that arose
from lateral gene transfer (LGT) from bacteria (7–9). Indeed, recent bioinformatic
analyses suggested that LGT might be a common genetic process during the evolution
of parasitic eukaryotes (10). Of note, monoxenous species of the genera Angomonas
and Strigomonas are characterized by the presence of obligate endosymbiotic Betapro-
teobacteria that divide synchronously with their host cells (11) and that contribute to
the metabolism of the parasite by providing essential nutrients such as heme and
amino acids (7, 12, 13). Phylogenomic analyses have also indicated that many protein-
coding genes in Leishmania major were acquired through LGT, with the main donors
being Proteobacteria and other members of the gut microbiome of insect vectors (10,
14). Finally, LGT in Leishmania and related genera has been shown to be a dynamic
process, with LGTs uniquely detected in Leishmania and being lost in other genera at
a higher rate than that seen with universal trypanosomatid LGTs (15).
Infection of both insect and mammalian host implies metabolic adaptations depen-
dent on the environment encountered by promastigotes and amastigotes. In the
digestive tract of the sandfly vector, the energy and central carbon metabolism of
promastigote stages likely evolved to depend on the catabolism of plant sap-derived
sugars (16, 17) present in aphid honeydews that are intermittently ingested by the
sandfly vector following a blood meal. 13C stable isotope labeling studies have shown
that promastigotes exhibit a strong preference for sugars as carbon source and that the
sugars are catabolized via glycolysis, the pentose phosphate pathways, succinate
fermentation, and the tricarboxylic acid (TCA) cycle (18–20). These stages also coutilize
nonessential amino acids during periods of high growth and can use amino acids as
primary carbon source under low-glucose conditions (18–20). Leishmania amastigotes
are metabolically less active than promastigotes, although they still exhibit a preference
for sugars as carbon source, and are dependent on uptake and catabolism of sugars for
survival in the host macrophages (21, 22). Strikingly, amastigotes exhibit reduced
capacity to utilize nonessential amino acids but increased capacity to catabolize fatty
acids (FAs) via -oxidation to generate acetyl coenzyme A (acetyl-CoA) for the TCA cycle
and anaplerotic pathways (18, 20, 22–24). This stage-specific switch in central metab-
olism is consistent with proteomic analyses of both axenic and lesion-derived amasti-
gotes (25, 26). In particular, enzymes involved in degradation of unsaturated FAs by
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-oxidation (abundant targets being monounsaturated and diunsaturated FAs) such as
a putative 2,4-dienoyl-CoA reductase and trans-enoyl-CoA isomerase are significantly
more abundant in amastigotes (26).
Here, we assessed the relevance of the single putative 2,4-dienoyl-CoA reductase
(DECR) in L. major promastigote and amastigote stages. Phylogenetic analysis of DECR
protein sequence revealed that this protein had been acquired by LGT early in the
evolution of the trypanosomatids. Strikingly, this gene appears to have been retained
in trypanosomatids that have evolved intracellular lifestyles (e.g., in genera Leishmania,
Trypanosoma, and Angomonas) but has been lost in dixenous parasites with an exclu-
sively extracellular lifestyle such as T. brucei. 13C-labeling studies of decr-deficient
Leishmania parasites confirmed the activity of this enzyme. In vitro as well as in vivo
infection experiments demonstrated that loss of DECR is associated with loss of
virulence and the capacity to survive within host cells. Together, these data suggest
that the acquisition and retention of this enzyme involved in -oxidation of the
abundant diunsaturated FAs have been critical in allowing Leishmania and other
trypanosomatids to colonize intracellular niches.
RESULTS
Leishmania DECR is related to bacterial reductases. Comparative proteomic
analyses of Leishmania mexicana promastigotes and intracellular amastigotes previ-
ously revealed that several proteins associated with respiration, energy metabolism,
and parasite stress responses are upregulated in amastigote stages (26). The data
included several enzymes involved in FA metabolism, including the trifunctional en-
zyme alpha subunit (corresponding to L. major ortholog [LmjF26.1550]), putative
3-ketoacyl-CoA thiolase-like (LmjF31.1630), thiolase protein-like (LmjF31.1640), 3,2-
trans-enoyl-CoA isomerase (LmjF31.2250), and DECR (LmjF33.0830) proteins (26). BLAST
analysis indicated that most of the Leishmania enzymes involved in FA -oxidation
showed close sequence homology to equivalent enzymes in their vertebrate hosts. An
exception was the DECR protein, which showed high homology to bacterial NADPH-
dependent 2,4-dienoyl-CoA reductases and very limited sequence similarity to the
equivalent human reductase (see Table S1 in the supplemental material). Consistent
with previous proteomic analyses, we show here using DECR-specific antibodies that
expression of DECR is indeed highly upregulated in amastigote stages (Fig. 1A).
To further define the origin of Leishmania DECR, we conducted a detailed phylo-
genetic analysis of related DECR protein sequences in other kinetoplastids, as well as in
Alphaproteobacteria, Betaproteobacteria, Gammaproteobacteria, Spirochaeta, Actinobac-
teria, and Bacteroidetes species. Moreover, we included sequences encoding a protein
that is of unknown function but is annotated as a DECR-like protein in kinetoplastids.
Global phylogeny analysis of bacterial and kinetoplastid DECR homologs showed that
all of the kinetoplastid sequences, except the shorter DECR sequence of Leptomonas
seymouri, belonged to two clades, here referred to as the DECR and DECR-like clades
(Fig. 1B). Remarkably, these two clades were not each other’s closest relatives. Instead,
both formed robust groups with closer bacterial lineages (support values of 1 [DECR-
like] and 0.987 [DECR] for branching off the ancestor shared with their respective
nearest prokaryotic protein homologue and distinct summed-up branch lengths for
DECR and DECR-like clades corresponding to their most recent common ancestors
[MRCA], corresponding to 0.59 and 1.35 amino acid substitutions per site). This sug-
gests that DECR and DECR-like proteins do not represent paralogs that arose by way of
gene duplication but, more probably, represent the result of two events of indepen-
dent LGT of genes of bacterial origin.
To further understand the phylogenetic relationships within the two major clades of
kinetoplastid DECR homologs, we aligned all kinetoplastid DECR and DECR-like se-
quences with a selection of outgroup sequences (33 and 6 sequences [Fig. 1C] and 26
and 4 sequences [Fig. 1D], respectively). DECR-like sequences were present in all
kinetoplastids (Fig. 1C), whereas DECR was detected in monoxenous kinetoplastids and
in several dixenous kinetoplastids, which follow obligate intracellular lifestyles in their
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DECR Leishmania aethiopica L147
DECR Leishmania turanica strain LEM423
DECR Trypanosoma cruzi Dm28c
DECR Trypanosoma cruzi Sylvio X10/1
DECR Trypanosoma grayi ANR4
DECR Leishmania panamensis MHOM/COL/81/L13
DECR Trypanosoma cruzi marinkellei strain B7
DECR Leishmania major strain LV39c5
DECR Trypanosoma cruzi CL Brener Non-Esmeraldo-like
DECR Leptospira yanagawae WP 039929008
DECR Leptomonas seymouri ATCC 30220
DECR Leishmania major strain SD 75.1
DECR Leishmania sp. MAR LEM2494
DECR Leishmania donovani BPK282A1
DECR Leishmania arabica strain LEM1108
DECR Leishmania gerbilli strain LEM452
DECR Endotrypanum monterogeii strain LV88
DECR Leishmania tarentolae Parrot-TarII
DECR Angomona Deanei
DECR Leishmania mexicana MHOM/GT/2001/U1103
DECR Cycloclasticus sp. PY97M EPD13413
DECR Crithidia fasciculata strain Cf-Cl
DECR Leishmania infantum JPCM5
DECR Leptomonas pyrrhocoris H10
DECR Leishmania braziliensis MHOM/BR/75/M2903
DECR Leptomonas pyrrhocoris H10 Chr3
DECR Leishmania enriettii strain LEM3045
DECR Leishmania tropica L590
DECR Leptomonas seymouri ATCC 30220 Short
DECR Leishmania major strain Friedlin
DECR Trypanosoma cruzi Dm28c
DECR Leishmania sp. MAR LEM2494
DECR-like Leptomonas seymouri ATCC 30220
DECR-like Crithidia fasciculata strain Cf-Cl
DECR-like Trypanosoma brucei Lister strain 427
DECR-like Leishmania enriettii strain LEM3045
DECR-like Phytomonas sp. isolate Hart1
DECR-like Leishmania turanica strain LEM423
DECR-like Leishmania sp. MAR LEM2494
DECR-like Leishmania panamensis MHOM/COL/81/L13
DECR-like Leishmania gerbilli strain LEM452
DECR-like Trypanosoma cruzi marinkellei strain B7
DECR-like Leishmania major strain Friedlin
DECR-like Leishmania aethiopica L147
DECR-like Trypanosoma rangeli SC58
DECR-like Trypanosoma grayi ANR4
DECR-like Leishmania arabica strain LEM1108
DECR-like Trypanosoma cruzi CL Brener Non-Esmeraldo-like
DECR-like Trypanosoma brucei gambiense DAL972
DECR-like Trypanosoma cruzi Dm28c
DECR-like Trypanosoma congolense IL3000
DECR-like Leishmania tarentolae Parrot-TarII
DECR-like Angomona Deanei
DECR-like Leishmania braziliensis MHOM/BR/75/M2903
DECR-like Endotrypanum monterogeii strain LV88
DECR Strigomonas culicis EPY28990
DECR-like Leishmania donovani BPK282A1
DECR-like Leishmania infantum JPCM5
DECR Leptomonas seymouri ATCC 30220
DECR-like Trypanosoma cruzi Sylvio X10/1
DECR-like Trypanosoma evansi strain STIB 805
DECR-like Leishmania tropica L590
DECR Trypanosoma grayi ANR4
DECR Leptomonas pyrrhocoris H10
DECR Bodo saltans
DECR-like Trypanosoma vivax Y486
DECR-like Leishmania mexicana MHOM/GT/2001/U1103
DECR Angomona Deanei


















FIG 1 DECR expression in L. mexicana and phylogenetic analysis of bacterial and kinetoplastid DECR and
DECR-like homologs. (A) Cell lysates (40 g protein per lane) from axenic cultures of L. mexicana
(Continued on next page)
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vertebrate hosts (Fig. 1D). Interestingly, DECR genes were absent from dixenous
species, such as T. brucei, that colonize only extracellular niches in their respective
hosts. The only exception to the latter finding was Trypanosoma grayi (indicated by an
arrowhead in Fig. 1D), which has an exclusively extracellular lifestyle in its vertebrate
(crocodile) host. However, the T. grayi DECR is predicted to be truncated and therefore
to lack cofactor coordination residues at its N terminus, suggesting that it may not be
functional (see Fig. S1 in the supplemental material).
The structure of Leishmania DECR is similar to those of bacterial reductases.
Since the leishmanial DECR orthologues are homologous to bacterial DECRs, we aligned
the L. major and L. mexicana DECR proteins with Escherichia coli 2,4-dienoyl-CoA
reductase (FADH). The structure of E. coli FADH, representing the only solved structure
for a bacterial DECR (27), was previously shown to contain an iron-sulfur (4Fe-4S) cluster
and noncovalently coordinated flavin mononucleotide (FMN) and flavin adenine dinu-
cleotide (FAD) cofactors and was found to be functional as a monomer (27–31). The
leishmanial DECR-E. coli FADH alignment revealed that all residues involved in the
coordination of FAD, FMN, and the iron-sulfur cluster in the latter were conserved
within the former sequences (Fig. 2). Residues involved in substrate binding as well as
the catalytic residues (Tyr167 and His270) were also conserved. Most of the residues
involved in NADPH binding and 10 of 11 residues involved in FAD coordination were
located within the C-terminal 331 amino acids (Fig. 2).
Alignment of E. coli FADH, L. major, and L. mexicana DECR with their respective
DECR-like proteins, which has been included in the phylogenetic analysis, showed that
only 5 of 11 residues involved in FAD coordination, 7 of 9 residues involved in FMN
coordination, and 5 of 9 residues in the active site were conserved in the latter (Fig. 2).
This low match level was also found with DECR-like sequences of intracellular kineto-
plastids (Leishmania species and Trypanosoma cruzi) and of extracellular kinetoplastids
such as T. brucei and sequences from the free-living kinetoplastid Bodo saltans (Fig. S2).
To further predict the functionality of Leishmania DECRs, we modeled its three-
dimensional (3D) structure against E. coli FADH using the online tool “Swiss-model”
(https://swissmodel.expasy.org/). The models of L. major and L. mexicana DECR were
subsequently recalculated and energy minimization was performed using UCSF Chi-
mera (https://www.cgl.ucsf.edu/chimera/) and Amber force field (http://ambermd.org/
AmberModels.php). In silico structure prediction revealed a remarkable overall similarity
to E. coli FADH (Fig. 3). All relevant regions involved in FAD and FMN coordination, in
NADPH binding, and formation of the iron-sulfur cluster as well as the active site were
structurally conserved. Differences in the modeled leishmanial DECR structure resulted
mainly from insertions in sequences localized in loops and helices (Fig. 3), which should
not interfere with the predicted protein function. In contrast, modeling of L. major
DECR-like protein suggested steric orientation differences that did not allow formation
of an iron-sulfur cluster, even though all required cysteines were present.
L. major DECR is the major reductase involved in polyunsaturated fatty acid
-oxidation. To investigate whether L. major DECR is a functional enzyme, L. major
FIG 1 Legend (Continued)
amastigotes (Am) and promastigotes (Pro) were immunoblotted with an anti-DECR serum. Equal levels
of transfer were controlled by Ponceau S staining of the membrane before immune detection. (B) Overall
circular phylogenetic tree for 248 DECR and DECR-like homologous protein sequences. Maximum
likelihood analyses were performed using PhyML with the BEST tree search strategy. Branch robustness
was assessed with Shimodaira-Hasegawa-like approximate likelihood ratio tests (SH-like aLRT), with a
SH-like aLRT value of 0.995 supporting the branching off both the DECR and DECR-like sequences
containing clades of their last common ancestor and with values of 1 (DECR-like protein) and 0.987 (DECR
protein) supporting the branching off the last common ancestor shared with their respective nearest
prokaryotic protein homologues. Sequences are colored according to taxonomic affiliation indicated in
the legend. (C) Maximum likelihood phylogenetic tree of 33 kinetoplastid DECR-like protein sequences
using 6 DECR sequences representative of relevant genera as outgroup. Monophyly of DECR-like protein
sequences was indicated by SH-like aLRT branch support values of 0.96 or higher for the supraextant
genus level. (D) Maximum likelihood phylogenetic tree of 26 kinetoplastid DECR routed by 4 outgroup
sequences. Trees were constructed from multiple-sequence alignments followed by PhyML analysis. The
horizontal tree scale bar represents 0.1 substitutions per amino acid (aa) site. The arrowhead in panel D
indicates the dixenous extracellular trypanosomatid T. grayi.
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DECR null mutant parasites (L. major decr) were generated by replacing the entire
coding sequence of both genomic alleles with resistance markers through double
homologous recombination. L. major Δdecr promastigotes were readily obtained and
had a growth rate similar to that of wild-type (WT) promastigotes under standard
culture conditions (Fig. 4A). To partly mimic amastigote growth conditions, promastig-
otes were also cultured at 33°C for 2 days in semidefined culture medium (SDM).
Targeted liquid chromatography/mass spectrometry (LC/MS) analysis of total metabo-
lite extracts of the thus-cultured wild-type and decr L. major lines revealed a dramatic
accumulation of 2,4-decadienoyl-CoA, one of the key precursors of DECR generated
during the -oxidation of linoleic acid, as well as the complete loss of the DECR product
3-decaenoyl-CoA (Fig. 4B to D).
To further confirm the involvement of DECR in the -oxidation pathway, parasites
were incubated with 13C-labeled linoleic acid and the incorporation of 13C into inter-
mediates in central carbon metabolism was monitored by gas chromatography/mass
spectrometry (GC/MS). 13C-labeled linoleic acid was efficiently taken up by wild-type,
decr, and decr::DECR promastigotes and partly elongated to other FA, as shown by
the detection of 13C-labeled eicosaditraenoic and tetraenoic acids in all three parasite
strains (Fig. 5A). In wild-type promastigotes, 13C-labeled linoleic acid was also catabo-
lized by -oxidation to acetyl-CoA as shown by the incorporation of 13C labeling in TCA
cycle intermediates, such as citrate (Fig. 5B). The level of labeled citrate was repressed
in the L. major decr mutant and was restored in the complemented line (Fig. 5B). As
shown previously (20), most of the C2 carbon backbones derived from FA -oxidation
appeared to exit the TCA cycle during the first cycle (possibly for generation of
glutamate or malate). This was corroborated here by the specific generation of M2
isotopomers of citrate and by the absence of isotopomers of larger mass (Fig. 5C). The
M2 isotopomers of citrate were reduced to levels that were close to background
(natural abundance) levels in the L. major decr mutant (Fig. 5C) consistent with DECR
having a key role in -oxidation of major unsaturated FAs.
DECR is localized to mitochondria in Leishmania. The Leishmania DECR-like
protein has previously been localized to glycosomes that also contain other enzymes of
FIG 2 Sequence alignment of putative Leishmania DECR and DECR-like proteins. Sequence alignment of L. major DECR (LmjF.33.0830), L. mexicana DECR
(LmxM.32.0830), L. major DECR-like (LmjF.06.0930), and L. mexicana DECR-like (LmxM.06.0930) proteins with E. coli FADH (AP_003630) was performed using
Geneious 10 software (MUSCLE alignment). Amino acid residues involved in substrate binding as well as cofactor coordination were identified based on a crystal
structure of E. coli FADH (27) and are highlighted with colored boxes. Red boxes, residues involved in FMN coordination; blue boxes, residues of the active site
responsible in substrate binding; purple boxes, residues involved in FAD coordination; green boxes, residues involved in 4 Fe-4 S cluster coordination.
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FA metabolism (32), while the precise localization of DECR has not been determined
(32–35). To localize the DECR protein, a C-terminal fusion protein containing mNeon-
Green was expressed from the native gene loci. Direct fluorescence microscopy of live
promastigotes expressing DECR-mNeonGreen showed that this protein is exclusively
located in the mitochondria. In stationary-phase promastigotes, the mitochondrion has
a distinct tubule structure that extends from the anterior flagellar pocket to near the
posterior end of the cell (labeled with MitoTracker Red CMXRos in Fig. 6A). Interestingly,
DECR-mNeonGreen was not uniformly distributed throughout the mitochondrion but
was concentrated within a subdomain of the mitochondrion, which was invariably
located proximal to the nuclear envelope (Hoechst staining). The identity of this
subdomain remains undefined but might correspond to endoplasmic reticulum (ER)-
mitochondrion junctions (or to mitochondrion-associated membranes [MAMs]) found
in other eukaryotes. The DECR-mNeonGreen protein also colocalized with MitoTracker
Red fluorescence in amastigotes (Fig. 6A). As with the promastigotes, there was some
evidence of compartmentalization of DECR within the mitochondrion of amastigotes,
although not to a single domain. No overlap was observed for the DECR-mNeonGreen
protein and the glycosomal marker (mCherry–fructose-1,6-bisphosphatase [mCherry-
FBPase]), indicating that DECR is not targeted to glycosomes (Fig. 6B). These visualiza-
tions and the results of their quantitative analysis (Fig. 6C) suggest that DECR is
exclusively located to the mitochondrion in both major developmental parasite stages.
DECR is a virulence factor in Leishmania. To determine whether DECR and
-oxidation of major diunsaturated FAs are required for intracellular growth and
virulence, bone marrow-derived macrophages (BMDMs) were infected with L. major
wild-type, mutant Δdecr, or complemented Δdecr::DECR parasites and growth was
monitored for 9 days. All strains were taken up by BMDMs equally well (Fig. 7A). Mutant
parasites lacking DECR were cleared over 24 h. In contrast, both wild-type and com-
plemented L. major Δdecr::DECR parasites survived this initial period (Fig. 7A) and
resumed growth over the day 9 postinfection observation period (Fig. 7A and B).
FIG 3 Model of L. mexicana DECR with differences from the E. coli FADH structure. Differences between
L. mexicana DECR and E. coli FADH are highlighted in yellow. These are mainly in loop regions that
resulted from insertions into the leishmanial DECR sequence. The solid mesh body represents contact
area between protein and substrate.
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The virulence of the L. major decr mutant was also assessed in the highly suscep-
tible BALB/c mouse model. Mice were infected subcutaneously at the base of their tails,
and lesion sizes were scored over a period of 8 weeks. Corroborating the infectivity
results in BMDMs, L. major wild-type and L. major Δdecr::DECR parasites induced lesions
that reached a size of 5 to 10 mm (lesion score 3), at which point animals had to be
euthanized. In contrast, L. major Δdecr parasites failed to develop quantifiable lesions
(lesion score 0; Fig. 7C). However, as often observed with attenuated Leishmania mutant
lines (36–38), limiting dilution culturing from tissues at the site of injection revealed
that some L. major Δdecr parasites persisted 8 weeks post in vivo infection. Thus, DECR
is a virulence factor and decr-deficient parasites were unable to cause lesions in a highly
susceptible host.
DISCUSSION
In the present study, we characterized the function of DECR, an enzyme that is
highly upregulated in intracellular pathogenic stages of Leishmania and involved in the
-oxidation of unsaturated FAs. Phylogenetic analyses suggested that DECR had been
acquired by LGT from a bacterial donor early during the evolution of kinetoplastids,
adding to the pathway of FA -oxidation in mitochondria. The results of our genetic
and biochemical studies suggest that DECR is the major 2,4-dienoyl-CoA reductase in
these parasites and essential for intracellular parasite growth and virulence in animal
models, highlighting the importance of FA catabolism for virulence.
In the last 4 decades, the structure and activity of both peroxisomal and mitochon-
FIG 4 Loss of DECR does not affect promastigote growth in vitro but is associated with changes in intracellular levels of specific acyl-CoA species. (A)
Competitive growth in the presence of a wild-type, GFP-expressing L. major was used to compare relative levels of fitness in one culture sampled at the
indicated days over a 5-day observation time by flow cytometry. Cultures were initiated with mixes of 3  105 parasites of each strain and reached densities
of 107 parasites per ml. (B) Linoleic acid-derived 2,4-decadienoyl-CoA is converted to 2-decaenoyl-CoA and by DECR (double bond position inferred based
on the mode of action of E. coli FADH [27]). (C and D) LC/MS was used in selected ion monitoring mode to detect (C) 2,4-decadienoyl-CoA (m/z 916.21240) and
(D) 2-decaenoyl-CoA (m/z 918.22805) in extracts from 2  108 parasites per sample. Shown are data points corresponding to independent biological samples
and their means with standard deviations (SD).
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drial eukaryotic DECR enzymes have been extensively characterized (39–43) (for re-
views, see references 44 and 45). Moreover, it has been observed that DECR deficiency
is associated with severe disorders in mice and humans (46–48). To date, the investi-
gation of prokaryotic and eukaryotic DECR function has been restricted to model
organisms such as E. coli and Saccharomyces cerevisiae (27, 29–31, 49). Although the
relevance of lipid metabolism in trypanosomatids has been broadly studied (50–52), the
-oxidation pathway of major unsaturated FAs in these organisms has received little
attention. In trypanosomatid genomes, two genes are annotated as encoding proteins
with homology to bacterial DECR, the putative DECR and DECR-like proteins.
Our in silico analyses demonstrated that the Leishmania and T. cruzi DECR proteins
retain the same structure and residues involved in cofactor coordination and substrate
binding as the E. coli DECR ortholog FADH. These analyses indicated that trypanoso-
matid DECRs are active reductases. This was experimentally confirmed by targeted
metabolomic analysis of the Leishmania Δdecr mutant, which showed that a major
substrate of DECR, 2,4-decadienoyl-CoA, accumulated in the absence of the enzyme. In
contrast, structural predictions for decr-like gene-encoded proteins indicated that they
may not bind required cofactors due to significant differences in amino acid residues
involved in their coordination and are likely not contributing to reduction of 2,4-
decadienoyl-CoA by the parasites. Divergences between DECR and DECR-like proteins
also extend to their localization. The DECR-like protein is thought to be localized to the
glycosomes of Leishmania and Trypanosoma species (33–35). In contrast, we show here
that the Leishmania DECR protein is localized to the mitochondrion. Interestingly,
results of direct fluorescence microscopy imaging of live promastigotes suggested that
FIG 5 DECR is required for -oxidation of linoleic acid in vivo. (A) L. major promastigotes were labeled with 13C-labeled
linoleic acid and levels of selected 13C-FAs determined as methyl esters by GC/MS. 13C-labeled linoleic acid is incorporated
into parasites. Shown are means with standard errors of the means (SEM) representing results from four, three, and two
parasite cultures grown with WT, Δdecr, and Δdecr::DECR L. major, respectively. (B) L. major promastigotes were labeled with
13C-labeled linoleic acid and levels of 13C label incorporated into citric acid determined by GC/MS. Data represent means
with SEM of results from four cultures (*, P  0.05). (C) Analysis of citric acid mass isotopologues generated after 13C linoleic
acid labeling. Data represent means with SEM of results from four, three, and two parasite cultures grown with WT, Δdecr,
and Δdecr::DECR L. major, respectively (*, P  0.05).
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the DECR-mNeonGreen reporter protein was concentrated in a subdomain of the
mitochondrion juxtaposed to the ER-nuclear envelope. Similar junctions between the
mitochondria and ER occur in other eukaryotes and are associated with intraorganellar
transport of phospholipid precursors (53). Whether DECR is concentrated within these
MAM domains and the functional significance of this additional compartmentalization
need to be investigated.
DECR has been transferred to kinetoplastids, likely from proteobacteria by LGT (10,
15). Extant Leishmania genomes have been significantly affected by prokaryote-to-
eukaryote LGT, with 0.96% of the protein-coding genes originating from LGT events,
the highest percentage among microbial parasites (10). The relevance of LGT for the
development of an intracellular life cycle has recently been highlighted by the descrip-
tion of the acquisition and subsequent evolution of a family of dual-activity
glycosyltransferase-phosphorylases in Leishmania spp. (54). With respect to DECR,
previous studies on LGT in trypanosomatids did not differentiate between DECR and
DECR-like proteins. However, in doing so, we propose that these genes were acquired
in two independent events and that extracellular parasites such as the African trypano-
somes may have lost DECR subsequently. This gene loss event accounts for an
evolutionary path of the DECR locus that is consistent with the evolution of this family
of organisms.
Acquisition by separate LGT events rather than by gene duplication and diversifi-
cation is most consistent with the results of our analysis. Accordingly, a DECR-like gene
was acquired first in an ancestral kinetoplastid and DECR gene transfer happened most
likely after the divergence of free-living and parasitic kinetoplastids. However, the
FIG 6 DECR localization in L. mexicana and L. major. (A) Live L. mexicana promastigotes and amastigotes expressing DECR-mNeoGreen were labeled with
Hoechst (nuclei) and MitoTracker Red CMXRos (mitochondrion) and imaged by confocal microscopy. DIC, differential inference contrast. (B) L. mexicana
promastigotes expressing DECR-mNeonGreen and FBPase-mCherry (glycosome marker) were fixed and imaged by confocal microscopy. Nuclei were stained
with Hoechst. Scale bars: 10 m. Scale bars for magnification: 2.5 m. (C) Quantitation of colocalization. Pearson’s correlation coefficient (PCC) and Manders’
thresholded coefficients tM1 and tM2 were calculated using Costes’ automatic threshold regression on the deconvolved images. The data in the graphs present
results from two independent experiments, each represented by several images (n  5). Error bars refer to standard deviations.
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description of this scenario needs a cautionary note, since (i) the estimates of the 95%
highest posterior densities of the most recent common ancestors (MRCA) overlapped
(i.e., the order of the transfer events was not firmly ascertained, although our Bayesian
Monte Carlo Markov chain [BMCMC] analyses indicated a more recent MRCA for
kinetoplastid DECR protein than for kinetoplastid DECR-like protein), (ii) detection of
the DECR gene in B. saltans genome might have failed or it might have been lost
secondarily in this lineage, and (iii) the bacterial group(s) at the origin of the DECR and
DECR-like LGTs could not be resolved based on current knowledge. Nevertheless, the
kinetoplastid DECR and DECR-like gene orthologs separated from clearly different
closest related bacterial lineages.
DECR loss in nonintracellular trypanosomes appears to have occurred independently


















































L. major ∆decr 
L. major ∆decr::DECR (Line B)
L. major ∆decr::DECR (Line A)
FIG 7 In vitro and in vivo infection assays. BMDMs were infected (multiplicity of infection [MOI] of 10)
with stationary-phase wild-type (L. major WT), DECR-deficient (L. major Δdecr), or complemented DECR-
deficient (L. major Δdecr::DECR) L. major promastigotes for 2 h. (A) Infection rate data are expressed as
percentages of infected BMDMs and were determined by microscopy (at least 100 macrophages were
counted). Data from one experiment representative of three is shown. (B) Infected BMDMs were washed
to remove noninternalized parasites and further cultivated for 9 days. Cells were fixed with 4% parafor-
maldehyde (PFA), and DNA was stained using DAPI. (C) BALB/c mice were infected subcutaneously at the
base of their tails with L. major WT (n  3), L. major Δdecr (n  3), and two independent L. major
Δdecr::DECR complemented lines (both n  2) (2  106 promastigotes in the stationary phase of growth).
Developing lesions were scored every week using the following lesion scores: 0, no swelling; 1, swelling
or lesion size of 1 mm; 2, lesion size of 2 to 5 mm; 3, lesion size of 5 to 10 mm; 4, lesion size of 10 mm.
Mice with lesion scores of more than 3 or 4 were euthanized. The average lesion score is indicated.
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respective genomic regions of the DECR and DECR-like genes (see TriTrypDB [http://
tritrypdb.org/tritrypdb/]). The cistronic regions upstream of DECR loci are characterized
by the presence of -tubulin genes. Synteny in this region is less conserved among the
sequenced genomes (see, e.g., https://tritrypdb.org/tritrypdb/app/record/gene/LmjF.33
.0830#SyntenyGbrowseUrl) than for the respective region upstream of DECR-like genes,
indicating that the DECR locus is in a region prone to frequent genomic rearrange-
ments. Rearrangement of this region would also explain the situation found in T. grayi,
which possesses only a truncated version of the DECR gene encoding a likely nonfunc-
tional, N-terminally shortened protein. Loss of DECR in extracellular trypanosomes
corroborates the existence of selective pressure acting on intracellular trypanosomatids
to maintain DECR gene integrity and hence enzyme activity for survival and growth.
Indeed, genome data revealed that DECR is present in trypanosomatids that have
the capacity to survive intracellularly. Of particular note is the presence of DECR genes
in monoxenous kinetoplastids (Angomonas deanei, Crithidia spp., Leptomonas spp.). For
example, A. deanei, previously named Crithidia deanei, was shown to be infective to, in
particular, dexamethasone-immunosuppressed BALB/c mice (55, 56). Parasites related
to Crithidia fasciculata (57) and L. seymouri, respectively, were identified as coinfecting
or sole agents in immunocompromised HIV patients diagnosed with leishmaniasis
(58–60). The clinical cases show that monoxenous trypanosomatids of genera or
species that are normally considered nonpathogenic can survive within vertebrate
hosts and host cells, in particular, in immunocompromised hosts (57, 59, 61–63).
Genetic deletion of DECR in Leishmania led to a loss of virulence in both macro-
phage and animal infection models. There are a number of possible explanations for
loss of virulence. First, it is possible that intracellular amastigotes are dependent on FA
as a major carbon source. In particular, -oxidation of major unsaturated FA species
may be required for production of acetyl-CoA in the mitochondrion and for anaplerotic
production of citrate and glutamate via the initial steps in the oxidative TCA cycle (19,
20). De novo synthesis of glutamate appears to be essential in amastigotes, which have
a greatly reduced capacity to take up nonessential amino acids (20). However, while our
metabolomic analyses of parasites labeled for extended times showed that loss of DECR
leads to a complete block in final steps in unsaturated FA -oxidation, the mutant may
still be able to generate minor amounts of acetyl-CoA during the non-DECR-dependent
cycles of this process. Interestingly, the accumulation of DECR substrates in mammalian
cells has been shown to inhibit -oxidation of other FA (64), resulting in a global defect
in FA -oxidation. While our results are consistent with a complete block of -oxidation
in the DECR mutant, this will have to be investigated in future studies.
Alternatively, or in addition, DECR may be required to prevent accumulation of toxic
levels of unsaturated FAs in intracellular parasite stages. Free FAs are evolutionarily
ancient innate immunity effector molecules with potent microbicidal activity and play
a prominent role in defense in organisms from mollusks to humans (65, 66). In general,
unsaturated FAs exhibit greater antimicrobial activity than saturated FAs and unsatu-
rated FAs with double bonds in cis orientation are more toxic than those with double
bonds in trans orientation (67, 68). Cell lysis, lipid peroxidation, and impairment of
nutrient uptake are thought to be toxic consequences of the effects of FAs on bacteria
(69, 70).
Free FAs are also cytotoxic to eukaryotic cells such as S. cerevisiae (71–73) and to
pathogenic protozoa such as Plasmodium spp. in vivo and in vitro (74, 75). Significantly,
the intracellular parasite Toxoplasma gondii presumably lacks a functional -oxidation
pathway but has retained a DECR protein of the eukaryotic peroxisomal family (see
Toxoplasma gondii ME49_226300[TGME49_226300] in ToxoDB [https://toxodb.org/
toxo/app/record/gene/TGME49_226300]). T. gondii tachyzoites readily take up host FAs
(76), but supplementary addition of unsaturated FAs (not saturated FAs) was previously
shown to impair parasite growth and replication in host fibroblasts (77). However, we
have found that neither the wild-type nor DECR-deficient L. major parasites are sensi-
tive to physiologically relevant concentrations of free FA. Specifically, a 5-fold excess
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over the usual cell culture levels of free linoleic acid did not affect in vitro growth (see
Fig. S3 in the supplemental material).
Lack of DECR could also have led to reductive stress in mitochondria, thereby
affecting viability. However, the mutants were not different from the parental wild-type
parasites when exposed to increasing concentrations of dithiothreitol (DTT) or N-acetyl
cysteine, commonly used to assess susceptibility to reductive stress (see Fig. S4).
Finally, it is possible that intracellular amastigotes may be highly sensitive to
accumulation of DECR substrates, such as 2,4-decadienoyl-CoA. While the accumulation
of this intermediate was not lethal to promastigote stages, it was able to lead to
dysregulation of mitochondrial function and production of additional oxidative stress
that is lethal in the intramacrophage niche (20). As said above, accumulation of DECR
substrates in mammalian cells (64) led to a global halt of -oxidation.
In summary, we show that the acquisition of a mitochondrially located homologue
of a DECR gene by early trypanosomatids via LGT is likely to have enhanced the
metabolic fitness of these protists in their insect vectors and subsequently to have
allowed several medically important pathogens to evolve intracellular lifestyles in their
mammalian hosts. The bacterial origin of the DECR homologues could be exploited in
the development of specific antileishmanial therapies.
MATERIALS AND METHODS
Growth of Leishmania parasites. L. mexicana mexicana (MNYC/BZ/62/M379) expressing DsRed (78)
and wild-type L. major (WHOM/IR/-/173) (L. major WT) (79) as well as decr-deficient L. major (L. major
Δdecr) and decr-complemented L. major (L. major decr::DECR) strains were cultured in semidefined
culture medium (SDM) supplemented with 10% heat-inactivated fetal bovine serum (FBS), 0.1 mM
adenine, 1 g/ml biotin, 5 g/ml hemin, and 2 g/ml biopterin (all from Sigma-Aldrich, Steinheim,
Germany). For metabolic analyses, L. major parasites were adapted and further cultivated in completely
defined medium (CDM [80]) containing 0.75% essentially FA-free bovine serum albumin (BSA) (Sigma-
Aldrich, Steinheim, Germany) supplemented with 100 U/ml penicillin and 0.1 mg/ml streptomycin
(Capricorn Scientific, Ebsdorfergrund, Germany). Promastigotes were incubated at 25.5°C with 5% CO2.
Differentiation of L. mexicana promastigotes to amastigotes in axenic culture was carried out as
described previously (26). Briefly, stationary promastigotes were diluted 1 to 10 in Schneider’s Drosophila
medium (Sigma-Aldrich, Steinheim, Germany) supplemented with 20% heat-inactivated fetal bovine
serum (Gibco, Paisley, United Kingdom) and adjusted to pH 5.5 and were incubated for 1 week at 33°C
until differentiation into amastigotes was accomplished.
Generation of decr-deficient and complemented Leishmania major. In order to generate DECR
deletion mutants, the 5=-flanking and 3=-flanking regions of DECR of L. major were amplified from
genomic DNA (gDNA) and ligated into the pUC18 vector together with either the hygromycin resistance
gene or the neomycin resistance gene. A HindIII-linked 5= primer (5=-GCTAAGCTTGAGTCTTGTCAGTCCT
TCTTG-3=) and a SpeI/XbaI-linked 3= primer (5=-GCTTCTAGACTAGTTTTTGTGCAATTTCGTTGCCG-3=) were
used for the 5=-flanking region and a BamHI-linked 5= primer (5=-GCTGGATCCGGGTCGACTAGGTTGCCG
TCAC-3=) and a HpaI/KpnI-linked 3= primer (5=-GCTGGTACCGTTAACGGCACCAGCACACCACAGCA-3=) were
used for the 3=-flanking region for the amplification of flanking regions necessary for the homologous
recombination. The 5=-flanking region was subjected to HindIII and XbaI digestion and introduced into
the HindIII/XbaI cut of the vector. The hygromycin resistance gene was subjected to SpeI and BamHI
digestion and introduced into the SpeI/BamHI cut. The 3=-flanking region was subjected to KpnI and
BamHI digestion and introduced into the KpnI/BamHI cut of the plasmid (for better understanding of the
following cloning strategy, this construct is referred to here as plasmid A). In order to obtain the final
plasmid containing neomycin as a selection marker, the hygromycin resistance gene was replaced by the
neomycin resistance gene using both digestion with plasmid A and insertion with SpeI and BamHI. Every
cloning step was verified by restriction digestion and sequencing. In order to obtain fragments for
homologous recombination, flanking regions together with the resistance gene were excised from the
generated plasmids using MluI and HpaI.
The strategy for the generation of a complemented strain consisted in the reinsertion of the DECR
gene at its original locus in L. major decr-deficient parasites. Therefore, hygromycin or neomycin
resistance genes were replaced by bleomycin resistance genes for selection. This resistance gene was
amplified from a previously constructed unpublished vector containing bleomycin resistance gene
between the two above-mentioned DECR-flanking regions. For this purpose, a SpeI-linked 5= primer
(5=-CGGACTAGTCATGGCCAAGTTGACC-3=) and an XbaI-linked 3= primer (5=-CGGTCTAGAGGTCAGTCCTG
CTCCT-3=) were used. The fragment was then subjected to SpeI and XbaI digestion and introduced into
the SpeI/XbaI cut of pSSU-int vector, which contains the intergenic region of the cysteine proteinase B
(CPB) 2.8 gene cluster of L. mexicana (CPB 2.8 inverted repeat [IR] [81]), replacing the original hygromycin
resistance gene. The resulting plasmid (called plasmid B) was then subjected to SpeI and KpnI digestion,
and the isolated bleomycin-CPB 2.8 IR fragment was inserted in plasmid A, which had previously been
subjected to SpeI and KpnI digestion, in order to remove the hygromycin resistance gene and 3= flanking
region. The resulting plasmid (called plasmid C) contained the 5´flanking region, bleomycin resistance
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gene, and CPB 2.8 IR region. The decr gene and its 3= flanking region were amplified from L. major gDNA
using a KpnI-linked 5= primer (5=-CGGGGTACCATGAAGCAGTACGCAAAGAT-3=) and a KpnI-linked 3=
primer (5=-CGGGCTCTTTCGCTTGCCGATCACAACCGTC-3=). The fragment was digested with KpnI and
introduced by nondirectional cloning into KpnI cut downstream of the CPB 2.8 IR region of plasmid C.
Orientation of the different fragments in the final construct was checked by asymmetric restriction
digestion and sequencing, and the results were linearized using AseI/HindIII for transfection experiments.
Transfection of L. major. Promastigotes (2  107) in the logarithmic-growth phase were transfected
with 3 to 5 g DNA by electroporation using a human T cell Nucleofector kit (Lonza, Basel, Switzerland).
After 24 h of culture in SDM, selection pressure was applied by supplementing the medium with
16 g/ml hygromycin B (Carl Roth, Karlsruhe, Germany), 16 g/ml G418 (Carl Roth, Karlsruhe, Germany),
or 40 g/ml bleomycin (InvivoGen, San Diego, CA, USA). After 1 week, cultures in 48-well plates were
analyzed for proliferating parasites. These were passaged three times until a line was considered stable.
Genomic DNA was obtained and homologous recombination was verified by PCR and sequencing.
Knockout of DECR of both copies was checked and the possibility of retention of an extra copy of
chromosome 33 in double knockout parasites excluded using Southern blot analyses and DECR ORF-
specific PCR and Western blot analysis using a DECR-specific antiserum (see below).
DECR data sets and multiple-sequence alignments. We gathered 10,561 bacterial and kinetoplas-
tid DECR/NADPH-dependent DECR protein sequences from public databases (TriTrypDB for DECR and
DECR-like protein sequences of trypanosomes; NCBI integrated in Geneious for DECR and NADPH-
dependent DECR protein sequences of betaproteobacteria and gammaproteobacteria, as well as for
DECR protein sequences of Marinobacter and Corynebacterium) and from BLAST-P analysis performed
using the DECR protein sequences of Bodo saltans and L. major as query sequences, which we aligned
using MAFFT (82). We selected conserved alignment blocks using gblocks (83) as implemented in
SeaView v4 (84) and then used FaBox v1.41 (85) to identify the 3,092 unique sequences in the alignments
of the resulting 510 amino acid positions.
To investigate the deep evolutionary history and the origins of kinetoplastid homologs of DECR, we
reduced this data set to sequences exhibiting at least 20% divergence with T-Coffee (86). The final
alignment comprised 248 sequences, including 12 sequences derived from kinetoplastids.
Phylogenetic analyses. We used Prottest v3.2 to perform model selection on the three alignments,
using a full maximum likelihood (ML) optimization and the Bayesian information criterion for model
comparison (87); in all cases, the selected model was LGIGF. We then ran phylogenetic analyses in
ML (for all alignments) and Bayesian frameworks (for the first alignment).
ML analyses were performed using PhyML v3 (88) with the full optimization and BEST tree search
strategy and assessing branch robustness with Shimodaira-Hasegawa-like approximate likelihood ratio
tests (SH-like aLRT) (89). The resulting tree was rooted using Tempest by minimizing the variance of
root-to-tip distances (90).
For the first alignment, we also ran multiple Bayesian Monte Carlo Markov chain (BMCMC) runs with
BEAST v1.8.2 (91), using a lognormal relaxed clock and a birth-death speciation model for tree shape. We
checked run convergence and appropriate sampling of the posterior (with effective sample sizes being
200) using Tracer v1.6 (http://tree.bio.ed.ac.uk/software/tracer/), combined different run outputs using
LogCombiner v1.8.2. (distributed with BEAST), and summarized the posterior set of trees (PST) on the
maximum clade credibility tree using TreeAnnotator v1.8.2 (distributed with BEAST). Branch robustness
was assessed with posterior probabilities. Node depths (expressed as numbers of amino acid substitu-
tions per site) of the most recent common ancestors (MRCA) of kinetoplastid DECR and DECR-like
sequences were extracted from the PST.
LC/MS analysis of parasite metabolites. L. major strains were cultivated in completely defined
medium (CDM) containing 5 mM glutamate until they reached the late logarithmic phase. Parasites were
harvested by centrifugation, washed once with phosphate-buffered saline (PBS), and resuspended in
glucose-free CDM supplemented with 13C-labeled linoleic acid (Cambridge Isotopes Laboratories, An-
dover, MA, USA) and 5 mM glutamate at a density of 0.75  106 parasites/ml. Parasites were incubated
at 33°C for 24 h and quenched in the late logarithmic phase in a dry-ice-cooled ethanol bath and
harvested by centrifugation and washed thrice in cold PBS before further processing and extraction of
metabolites.
We used a modified version of a previously reported untargeted LC/MS workflow (92) for our
targeted LC/MS analysis of the main DECR product and substrate. For extraction, the cell pellets were
dissolved in acetonitrile/water (8:2 [vol/vol]) by sonication in a water bath and insoluble material was
separated by centrifugation (21,500  g, 10 min, 0°C). Samples (10 l) were analyzed on a Thermo Fisher
Vanquish ultra-high-pressure liquid chromatograph coupled to a Thermo Q Exactive mass spectrometer.
Metabolites were separated on a SeQuant pHILIC column (450 by 4.5 mm with 5-m pore size). The
chromatographic gradient used started with solvent A (80% AcN) and solvent B (20% 20 mM NH4HCO3)
for 1 min. Solvent B was linearly increased to 80% over 18 min and further to 95% over 2 min. The column
was equilibrated to starting conditions for 4.5 min before the next sample was injected. Samples were
run in a randomized order with regular blanks and pooled biological controls. Metabolites were ionized
in a heated electrospray H-EASY II ion source in negative mode at 3.5 kV. Nitrogen gas flow parameters
were set to 40 for sheath gas, 5 for auxiliary (aux) gas, and 0 for sweep gas. The transfer capillary was
heated to 275°C and the S-lens radio frequency (RF) level set to 55. The mass spectrometer was calibrated
in negative-ionization and positive-ionization modes immediately before analysis was performed using
the corresponding Calmix reagents (Thermo Fisher, Waltham, MA, USA) and pyruvic acid. The mass
spectrometer was operated in selective ion monitoring mode with 0.5-atomic-mass-unit (amu) mass
isolation windows. Data were analyzed manually using the Qual Brower in Thermo Xcalibur 4.0.27.19
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software. 2,4-Cecadienoyl-CoA and 2-decaenoyl-CoA were identified based on the exact mass within a
5-ppm mass window, the expected isotope distribution, and a mass shift by 10.03 of 2,4-decadienoyl-CoA
in 13C-labeled linoleic acid-fed parasites. Metabolites were quantified in counts from extracts of 2  108
cells per sample.
Analysis of polar and apolar metabolites by GC/MS. GC/MS analysis of extracts was performed as
previously described (20) with a modified quenching procedure. Parasites were quenched by dilution
into excess ice-cold PBS, washed two times in PBS, frozen in liquid nitrogen, and stored at –70°C for
further analysis. The pellet was extracted in chloroform/methanol/water (1:1:3 [vol/vol]), and the super-
natant extracts were made biphasic by the addition of water containing 1 nmol internal standard
scyllo-inositol (final chloroform/methanol/water ratio, 1:2:1.4 [vol/vol]). Polar metabolites were dried and
methoxylated using 20 mg/ml methoxyamine–pyridine at room temperature for 16 h and trimethylsily-
lated in BSTFA/TMCS (Sigma-Aldrich, Steinheim, Germany) for 1 h at room temperature before being
analyzed on an Agilent 7890A-5975C GC/MS system (Agilent, Santa Clara, CA, USA) equipped with a 30-m
DB5 column. Fatty acids were analyzed as their corresponding methyl esters that were generated after
methanolysis of the dried chloroform phase in 0.5 M methanolic acid–HCl at 80°C overnight under a
partial vacuum. The data were analyzed using ChemStation software (version D.01.02.16; Agilent) and
DExSI (93).
Infection of mice and bone marrow-derived macrophages. All animal experiments were approved
by an ethics committee and licensed by the legal authorities under the license PPL 60/03581 (United
Kingdom), and the licenses T 0249/14 and H 0101/12 (Germany) to T. Aebischer. BALB/c and C57BL/6
mice were purchased from Charles River, Sulzfeld, Germany, and maintained in a conventional animal
facility. For in vivo infection experiments, mice were infected with 4  106 stationary-phase promastig-
otes at the base of the tail where lesions developed. Developing lesions were scored every week (94),
mice were killed by cervical dislocation at the end of the experiment, and lesion tissue was excised for
parasite isolation and further cultivation in axenic cultures. For in vitro infection studies, macrophages
were differentiated from bone marrow of 6-to-8-week-old female mice as described previously (95) and
were infected with axenic promastigotes at a multiplicity of infection of 10 for 2 h at 33°C with 5% CO2.
Before infection, promastigotes in the stationary phase were diluted 1:3 in Schneider’s Drosophila
medium (Sigma-Aldrich, Steinheim, Germany) supplemented with 20% heat-inactivated fetal bovine
serum (Gibco Paisley, United Kingdom) and with MES [2-(n-morpholino)ethanesulfonic acid] adjusted to
pH 5.5 for 24 h at 33°C. Infected cells were incubated for the indicated time points at 33°C and 5% CO2.
SDS-PAGE and Western blotting. Proteins were separated by the use of 10% SDS-PAGE (Bio-Rad,
Munich, Germany) and transferred to a nitrocellulose membrane using a semidry blotting system (Hoefer
Inc., Holliston, MA, USA). The protein transfer on the membrane was verified by staining with Ponceau
S solution, followed by decoloration with 0.1% acetic acid solution. Membranes were blocked with 5%
BSA dissolved in PBS (pH 7.3) containing 0.1% Tween 20 (PBS-T). In order to reduce unspecific binding,
anti-DECR serum (1:20,000 dilution) was preincubated for 30 min in blocking buffer containing 25% cell
lysate of decr-deficient parasites. Anti-DECR serum was generated by immunizing rabbits (Preclinics,
Potsdam, Germany) with three peptides corresponding to epitopes predicted to be located on the
surface of leishmanial DECR that were distinct from the DECR-like gene products. Secondary anti-rabbit
antibody was diluted in blocking buffer, and, after the membrane was washed twice with PBS-T and once
with PBS, a chemiluminescent reaction was carried out using SuperSignal West Dura (Thermo Fisher
Scientific, Darmstadt, Germany) and data were digitally acquired with a Bioimager.
Subcellular localization of DECR. DECR was C-terminally tagged with mNeonGreen using CRISPR/
Cas9 (96) (http://www.leishgedit.net). A L. mexicana (MNYC/BZ/62/M379) line constitutively expressing
Cas9 and T7 RNA polymerase (RNAP) was created after transfection with pTB007 plasmid (L. mexicana
T7Cas9) and was routinely maintained in RPMI 1640 –10% FBS containing 50 mg/ml hygromycin B Gold
(Invitrogen, Australia). The T7Cas9 line was transfected with small guide DNA (sgDNA) and donor plasmid
DNA, specific for the gene of interest. DECR-3= sgDNA was generated by PCR using 3=sgFP (GAAATTA
ATACGACTCACTATAGGAGCACTGCGTCGTACTGTGAGTTTTAGAGCTAGAAATAGC) and the universal sg-RP
(AAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTATTTTAACTTGCTATTTCTAGCTCTA
AAAC) and High Fidelity Phusion polymerase (New England Biolabs, Australia) in a 25-l volume
containing 0.2 mM deoxynucleoside triphosphates (dNTPs) and 2 M primers.
DECR donor DNA was amplified from plasmid pPLOTv1 Neo-mNeonGreen (96) with DECR-DFP
(CTGCAAGCTCATAGCGTGGCGATACGTCTGGGTTCTGGTAGTGGTTCCGG) and DECR-DRP (AAGAGGAAGAG
ACATCACGCTTGGCCCGCCCCAATTTGAGAGACCTGTGC) using High Fidelity Phusion polymerase (0.2 mM
dNTPs, 0.5 M primers, 2 U polymerase, 30 ng plasmid DNA, 1 M betaine [Sigma-Aldrich, Australia]) All
primers were designed using the software tool at http://www.leishgedit.net.
The glycosomal marker fructose-1,6-bisphosphatase (FBPase) was N-terminally tagged with mCherry
(pPLOTv1 puro-mCherry) (97). FBPase-5=sgDNA was produced with 5=sgFP (GAAATTAATACGACTCACTA
TAGGGGCTGCGGTAGGAGACCTGAGTTTTAGAGCTAGAAATAGC) and universal s-RP (AAAAGCACCGACTCG
GTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTATTTTAACTTGCTATTTCTAGCTCTAAAAC), using the same
PCR conditions as described above. FBPase donor DNA was amplified from plasmid pPLOTv1 puro-
mCherry (96) (http://www.leishgedit.net) with FBPase-UFP (CAACCCCCCCCCCCTTTCCACGTTCAACCCGT
ATAATGCAGACCTGCTGC) and FBPase-URP (AGTGGGAGTGGGGGTGCGCCTGATGTCCATACTACCCGATCCT
GATCCAG) using the same conditions as described above.
L. mexicana T7Cas9 promastigotes (mid-log phase, 4  107 cells/transfection) were suspended in
chilled electroporation buffer (EPB; 21 mM HEPES, 137 mM NaCl, 5 mM KCl, 6 mM glucose, 0.7 mM
Na2PO4, pH 7.4), in a 4-mm-path-length cuvette and electroporated with purified sgDNA and donor DNA
(combined in a 30-l volume) and pulsed twice at 1,700 V and 25 F with a 10-s interval in a Bio-Rad
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Gene Pulser XCell electroporation system (Bio-Rad, Australia). Cells were transferred to SDM containing
10% FBS and 100 units/ml penicillin/streptomycin. After 24 h, the medium was supplemented with
selection drugs, including puromycin (Stemcell Technologies, Australia) at 10 g/ml or Geneticin (G418;
MP Biomedicals, Australia) at 50 g/ml or both (hygromycin B was omitted at this stage). The selected
cell lines were maintained at 27°C in RPMI medium supplemented with 10% FBS. Cultures were
differentiated to axenic amastigotes in RPMI medium adjusted to pH 5.5 using 20% FBS at 35°C.
Fluorescence microscopy. To visualize mitochondria and glycosomes using fluorescence micros-
copy, live promastigotes and amastigotes were gently centrifuged (1,000 rpm, 5 min, room temperature)
and resuspended in medium containing 20 nM MitotrackerRED CMXRos (Molecular Probes, Eugene, OR,
USA) in RPMI medium lacking FBS for 5 min at room temperature. Cells were pelleted and resuspended
in PBS containing 1 g/ml Hoechst 33342 (Molecular Probes, Eugene, OR, USA) before being directly
settled onto coverslips that were coated with poly-L-lysine (Sigma-Aldrich, Australia) and sealed with nail
polish. Alternatively, parasites were fixed prior to imaging as follows. Cells were harvested by centrifu-
gation, washed once in PBS, and then fixed in 4% paraformaldehyde–PBS (15 min at 0°C) before being
washed three times in PBS and then settled onto poly-L-lysine-coated coverslips. Images were captured
using a Leica SP8 confocal microscope (inverted microscope; Leica Microsystems, Australia) and 488-nm,
552-nm, and 638-nm-wavelength laser lines and HyD detectors for fluorescence and LAS X SP8 software
(Leica microsystems, Australia). The different dyes were imaged using sequential frame collection, and
controls were used to exclude bleed-through. Images were acquired using a 100/1.4 oil lens objective.
Images were handled using imageJ (Fiji) software (98). Colocalization analysis was performed. All images
were deconvolved by the use of Huygens Professional version 19.04 (Scientific Volume Imaging, The
Netherlands; http://svi.nl) and the in/near object algorithm, with signal-to-noise ratios of 20 and 40
iterations. Fiji Coloc2 was used to calculate the Pearson’s correlation coefficient and Manders’ thresh-
olded coefficients tM1 and tM2 using Costes’ automatic threshold regression on the deconvolved
images.
For in vitro infection assays, cultured macrophages (2  105) were attached on 13-mm-diameter glass
coverslips in a 24-well plate and infected with adapted axenic L. major promastigotes as described above.
Cells were fixed with 4% (wt/vol) paraformaldehyde–PBS for 20 min. Cells were then washed with PBS,
and nuclei were stained with DAPI (4=,6-diamidino-2-phenylindole; Merck, Darmstadt, Germany) for
10 min in the dark at room temperature. After staining, the cells were washed three times with PBS and
the coverslips were mounted in Fluoromount (Sigma-Aldrich, Steinheim, Germany).
Cells were examined with a Zeiss Axio Observer Z1 microscope (Carl Zeiss, Jena, Germany). Images
were acquired and analyzed with ZEN (Blue Edition; Carl Zeiss, Jena, Germany). Fluorescence was
recorded aund an AxioCam MRm camera (Carl Zeiss, Jena, Germany) with 63 magnification and oil
immersion. Infected cells and the number of the intracellular parasites were counted using ImageJ
(Version 1.47m).
For cytofluometric analyses, 250-l volumes of the culture from green fluorescent protein (GFP)-
expressing (81) bacteria cocultured with nonexpressing strains were transferred into a fluorescence-
activated cell sorter (FACS) tube, centrifuged, and resuspended in 300 l CellFix (BD Biosciences) for
fixation. The samples were stored at 4°C until measurement.
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